🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Edgewise Therapeutics, Inc.

EWTX Healthcare
$32.7 +$0.01 (0.03%)
Market Cap: $3.52 B
Gurus Holding
2
Popularity Rank
#3258
% of Shares Held
0.04%
Net Activity (Q1 2026)
+$777,482.59

Guru Ownership Trend

Guru Analysis for Edgewise Therapeutics, Inc. (EWTX)

Edgewise Therapeutics, Inc. (EWTX), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q1 2026, a total of 2 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $1.26 M.

Top institutional holders include Paul Tudor Jones and Cliff Asness.

Institutional sentiment is currently Bullish. This is evidenced by a $777,482.59 net inflow during the quarter.

Recent activity highlights Paul Tudor Jones who opened a new position. Conversely, Cliff Asness reduced exposure by 37.9%.

Key Holders

Top 5 by Value

$941,504
$268,980

Top 5 by Conviction

Recent Activity Breakdown (Q1 2026)

+$941,504
Total Buy Value
New Buys 1
Additions 0
-$164,021.41
Total Sell Value
Reductions 1
Sold Out 0

Guru Consensus (Q1 2026)

Based on recent activity
Net Sellers
1
Net Buyers
1

FAQs for Edgewise Therapeutics, Inc. (EWTX)

Major holders include Paul Tudor Jones ($941,504), Cliff Asness ($268,980). According to the latest reported data, 2 tracked investment managers collectively hold approximately 38,428 shares.

According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $777,482.59, with 1 managers increasing positions and 1 managers reducing holdings.

During the most recent reporting period, 1 managers trimmed their positions, while 0 fully exited EWTX. The total reported sell value was $164,021.41.

Yes, 1 managers opened new positions in EWTX, and 0 increased their existing holdings. The total reported buy value was $941,504.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.00% New Buy 29,889 $941,504 Q1 2026
0.00% Reduce -37.9% 8,539 $268,980 Q1 2026
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form